Stephen D. Griffin - Jun 3, 2024 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
EVP, CFO and Treasurer
Signature
/s/ Stephen D. Griffin
Stock symbol
ANIK
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/5/2024, 04:10 PM
Previous filing
Apr 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Award $0 +38.5K $0.00 38.5K Jun 3, 2024 Common Stock 38.5K $0.00 Direct F1
transaction ANIK Stock Option (Right to Buy) Award $0 +96.5K $0.00 96.5K Jun 3, 2024 Common Stock 96.5K $29.35 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.
F2 Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
F3 The premium priced stock options vest in three equal annual installments beginning on June 3, 2025.